Literature DB >> 7889023

Rectal administration of nicomorphine in patients improves biological availability of morphine and its glucuronide conjugates.

P M Koopman-Kimenai1, T B Vree, L H Booij, R Dirksen.   

Abstract

The pharmacokinetics of 30 mg nicomorphine after rectal administration with a suppository are described in 8 patients under combined general and epidural anaesthesia. No nicomorphine or 6-mononicotinoylmorphine could be detected in the serum. Morphine appeared almost instantaneously with a lag-time of 8 min and had a final elimination half-life of 1.48 +/- 0.48 h. Morphine was metabolized to morphine-3-glucuronide and morphine-6-glucuronide. These glucuronide conjugates appeared after a lag-time of 12 min and the half-life of these two glucuronide conjugates was similar: about 2.8 h (P > 0.8). The glucuronide conjugate of 6-mononicotinoylmorphine was not detected. In the urine only morphine and its glucuronides were found. The renal clearance value for morphine was 162 ml.min-1 and for the glucuronides 81 ml.min-1. This study shows that administration of a suppository with 30 mg nicomorphine gives an excellent absolute bioavailability of morphine and its metabolites of 88%. The lipid-soluble prodrug nicomorphine is quickly absorbed and immediately hydrolysed to morphine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7889023     DOI: 10.1007/bf02178565

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  33 in total

1.  Mechanism of the renal tubular transport of morphine and morphine ethereal sulfate in the chicken.

Authors:  W M Watrous; D G May; J M Fujimoto
Journal:  J Pharmacol Exp Ther       Date:  1970-04       Impact factor: 4.030

Review 2.  Effects of renal insufficiency on the pharmacokinetics and pharmacodynamics of opioid analgesics.

Authors:  G L Chan; G R Matzke
Journal:  Drug Intell Clin Pharm       Date:  1987-10

3.  Morphine 6-glucuronide and morphine 3-glucuronide as molecular chameleons with unexpected lipophilicity.

Authors:  P A Carrupt; B Testa; A Bechalany; N el Tayar; P Descas; D Perrissoud
Journal:  J Med Chem       Date:  1991-04       Impact factor: 7.446

4.  Pharmacokinetics of nicomorphine and its metabolites in man after epidural administration.

Authors:  P M Koopman-Kimenai; T B Vree; M A Hasenbos; E W Weber; C P Verweij-Van Wissen; L H Booij
Journal:  Pharm Weekbl Sci       Date:  1991-06-21

5.  First-pass effect of morphine in rats.

Authors:  K Iwamoto; C D Klaassen
Journal:  J Pharmacol Exp Ther       Date:  1977-01       Impact factor: 4.030

6.  Pharmacokinetics of intravenously administered nicomorphine and its metabolites in man.

Authors:  P M Koopman-Kimenai; T B Vree; L H Booij; R Dirksen; G M Nijhuis
Journal:  Eur J Anaesthesiol       Date:  1993-03       Impact factor: 4.330

7.  The pharmacokinetics of morphine and morphine glucuronides in kidney failure.

Authors:  R Osborne; S Joel; K Grebenik; D Trew; M Slevin
Journal:  Clin Pharmacol Ther       Date:  1993-08       Impact factor: 6.875

8.  Pharmacokinetic interpretation of the enterohepatic recirculation and first-pass elimination of morphine in the rat.

Authors:  B E Dahlström; L K Paalzow
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

9.  Pharmacokinetics of morphine and its surrogates I: comparisons of sensitive assays of morphine in biological fluids and application to morphine pharmacokinetics in the dog.

Authors:  E R Garrett; T Gürkan
Journal:  J Pharm Sci       Date:  1978-11       Impact factor: 3.534

10.  Rectal administration of morphine hydrogel: absorption and bioavailability in women.

Authors:  D Westerling; K E Andersson
Journal:  Acta Anaesthesiol Scand       Date:  1984-10       Impact factor: 2.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.